All Posts Tagged With: "breast cancer"

Folic Acid intake

Higher Folic Acid intake in premenopausal woman is associated with 40% lower incidence of breast cancer.

“The results were higher intake of folate was related to reduced risk of breast cancer and this only applied to premenopausal women.”

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.nhiondemand.com/hsjarticle.aspx?id=1126&utm_source=NHI+OnDemand+Newsletter+List&utm_campaign=f18301c4e3-HSJ_Oct03_2011&utm_medium=email

Excerpt:

Date: 10/3/2011
Folate Associated with Reduced Risk of Breast Cancer
Source: American Journal of Epidemiology

Breast cancer is a cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare. Risk factors for breast cancer include gender, age, family history, defective genes, early onset of menstruation, late menopause and late childbearing. Breast cancer is about ninety percent due to genetic abnormalities that happen as a result of the aging process and the “wear and tear” of life in general.

 

Household products & women’s health problems

Linda’s comment: LISTEN-UP PEOPLE….I have been preaching this…..I have been on the lifelong daily detox for 2 years now….look at the FREE webinars on this sight on FIGHT….what you learn will save your life!!!

Dr. Gordon’s Comments: It bears repeating that we are all toxic but now this bright naturopathic doctor includes sources that most patients have never considered as contributing to their impaired health and even to breast cancer. Once patients see there is no escape they may be more compliant with the lifetime continual detoxification program I recommend including the use at least once a day of my “Power Drink” containing my Beyond Fiber, my Organic Green, BioEn’R-G’y C, and MACA. 

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.abc15.com/dpp/news/region_phoenix_metro/central_phoenix/phoenix-doctor-links-household-products-to-women%27s-health-conditions

Excerpt:

A Naturopathic physician in Phoenix says household products may be linked to a number of women’s health conditions. 

Dr. Marianne Marchese says household products may be linked to a number of women’s health conditions, and she put those findings in her new book 8 Weeks to Women’s Wellness. 

According to her book , the average person can store hundreds of chemicals in the body. 

One of her patients Sarara Corva tells us she believes common household items may have contributed to her breast cancer. 

Vitamin C – with comments from Linda & Dr. Gordon

Linda’s comments: Well I would blow their boxers off…I take 16,000 to 24,000 daily of the BioEnergyC from www.longevityplus.com My dogs get a minimum of 4000 mg in a one gallon water bowl….the five gallon water dish gets 20,000 mgs. I quiet frankly sick and tired of hearing the NIH and FDA and the pharmaceuticals squawk about taking high dosing of VitC….poor fellows, don’t have a clue…

Dr. Gordon’s Comments:

Everything  you think you know about vitamin C is probably more than 50% wrong  and, if you relied on this official appearing document re vitamin C, you would not use it.  The attached document is from NIH so it gives you all the negative but you must know all that too.

But I am providing you with the contrary opinion. You will be amazed at how the right hand of the government does not know what the left hand is doing! FDA has approved vitamin C for treating one type of cancer!  That opens the door to great speculation and further research about non-toxic cancer therapies and I am excited to incorporate into this program the power of PEMF, which makes each cell ALKALINE and restores transmembrane potential. So I believe I have two or more non-toxic approaches that need to be looked at concurrently and incorporated with my FIGHT program for long term success.

Using IV VIT C with  my FIGHT program and PEMF ( Pulsed Electromagnetic  Field Therapy )  you will see and feel results  with PEMF on top of my FIGHT program, I am clearly  getting younger!

There are other ways to enhance the effectiveness of high dose IV Vitamin C in treating cancer and using it alone I do not find that IV VIT C is very often curative but it almost always helps and buys time for other therapies to be instituted.

Remember   we all need to improve outcomes, as our patients pay cash. We are not endowed by Government funds like our brethren using their chemo/radiation.  They are generally covered and   just bill the system and are ok no matter what the outcome.  We are NOT OK unless we turn out superior results and have data that shows we can beat mainstream outcomes hands down.

This NIH authoritative appearing well– referenced document would make anyone think oral low dose (2000 mg and under) Vitamin C is dangerous and causes cancer and heart disease. It appears to be fully referenced up to date through November 2009 yet it is missing an important point; somehow IV vitamin C WITH K-3 is now FDA approved for treating bladder cancer!! After all if anyone knew that vitamin C could be FDA approved for one cancer then some doctors would have some interest in trying it in other cancers just like the oncologists do everyday.

How can I and many of our colleagues be successfully using oral and IV vitamin C to keep Cancer patients alive far longer than their oncologists predict and still be considered by mainstream oncologists to be so wrong?  They tell their patients to never use vitamin C!

This report even has recommendations about not exceeding what they have established now, as their safe upper limit of oral vitamin C at 2000 mg MAX. Yet it is hard for them to ignore entirely what we are doing with cancer so they throw in some words to try to sound plausible with their otherwise very negative review of vitamin C. This is BURIED in the attached report but of course they have their numbers about what the maximum serum levels achievable with oral vitamin c vs.  the high serum levels achievable with IV Vitamin C. Those that are interested to get to the bottom of this mystery will find that vitamin c deserves your serious attention, IV and ORAL because there is always the rest of the story.

This is just one paragraph from many articles you may want to review once you read my comments: ’The bottom line is: Apatone selectively targets and kills tumor cells using non-toxic biochemistry that protects surrounding healthy tissue.” Licensed in 2004 to IC-MedTech, Inc., a California-based biotechnology company, the first clinical trial began in 2005 to evaluate the drug in prostate cancer patients. The clinical studies, which were conducted at Summa Health System in Akron, Ohio and with Dr. Ananias Diokno at William Beaumont Hospital in Royal Oak, Mich., examined the safety and effectiveness in 17 end-stage prostate cancer patients for 12 weeks. These patients took Apatone orally each day. The trials were supported by the Beaumont Foundation, Summa Health System and IC-MedTech.

Yet this is the best that the NIH report can offer the informed patients and physicians trying to help cancer patients. They admit there could be some discrepancy in the research but clearly tell no one that vitamin C is working when mixed with the correct form of vitamin K-3 (Apatone), which increases its oxidative capacity.

Remember this  work using vitamin C  for cancer  goes back several years now  and it consists IV vitamin C with the correct form of vitamin K, which unfortunately it appears that  most physicians  have never found  the correct form since there appears to be as many as 6 molecules being sold as vitamin K-3 and some are toxic. Yet in the lecture I will deliver for The Oxidative Training Workshop during IMOSAIC on April 7th at the Minneapolis conference, sponsored by ACAM, AHIMA, AAEM and ICIM, I will educate you about how easily you can kill the therapeutic effect when you are trying to master oxidative therapies with something as simple as giving NAC or GLUTATHIONE concurrently.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/

Excerpt:

Introduction
Vitamin C, also known as L-ascorbic acid, is a water-soluble vitamin that is naturally present in some foods, added to others, and available as a dietary supplement. Humans, unlike most animals, are unable to synthesize vitamin C endogenously, so it is an essential dietary component [1].

Vitamin C is required for the biosynthesis of collagen, L-carnitine, and certain neurotransmitters; vitamin C is also involved in protein metabolism [1,2]. Collagen is an essential component of connective tissue, which plays a vital role in wound healing. Vitamin C is also an important physiological antioxidant [3] and has been shown to regenerate other antioxidants within the body, including alpha-tocopherol (vitamin E) [4]. Ongoing research is examining whether vitamin C, by limiting the damaging effects of free radicals through its antioxidant activity, might help prevent or delay the development of certain cancers, cardiovascular disease, and other diseases in which oxidative stress plays a causal role. In addition to its biosynthetic and antioxidant functions, vitamin C plays an important role in immune function [4] and improves the absorption of nonheme iron [5], the form of iron present in plant-based foods. Insufficient vitamin C intake causes scurvy, which is characterized by fatigue or lassitude, widespread connective tissue weakness, and capillary fragility [1,2,4,6-9].

Oral Vitamin K-3, with comments by Dr. Gordon

Could oral Vitamin K-3 activate oral Vitamin C so efficiently that it could be a viable alternative to IV Vitamin C for seriously ill patients needing oxidative therapies? In Vitro research is very promising and I will present more on this topic for the ACAM oxidative workshop mid-April in Minneapolis that I am doing with Robert Rowen and others. 

Now there are IN VIVO human trials so read the entire report attached and learn much more!  This is vital to saving lives. Many patients have been led to believe that nothing but IV Vitamin C can help extend their lives. Whereas we know that those that keep their Vitamin C urine test strips in the bright yellow range prove that they have high levels of vitamin C in their body at all times 24/7. By using the special vitamin C delivery system called BIOEN’R-G’Y C they seem to always live much longer than anyone expected. It now seems that they might add oral Vitamin K-3 and do even better! 

This is a key document  like the new Johnson And Johnson blood test for cancer followed always with a reference to Kobayashi and the tamoxifen/radiation article on breast cancer and the  Harvard Study on telomeres and age reversal in old mice with tamoxifen, which have all been shared with you on FACT. 

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com 

Excerpt:

The Vitamin C:Vitamin K3 System – Enhancers and Inhibitors of the Anticancer Effect

Davis W. Lamson, MS, ND; Yu-Huan Gu, PhD; Steven M. Plaza, ND, LAc; Matthew S. Brignall, ND; Cathy A. Brinton, ND; Angela E. Sadlon, ND

Abstract
The oxidizing anticancer system of vitamin C and vitamin K3 (VC:VK3, producing hydrogen peroxide via superoxide) was combined individually with melatonin, curcumin, quercetin, or cholecalciferol (VD3) to determine interactions. Substrates were LNCaP and PC-3 prostate cancer cell lines. Three of the tested antioxidants displayed differences in cell line cytotoxicity.

Melatonin combined with VC:VK3 quenched the oxidizing effect, while VC:VK3 applied 24 hours after melatonin showed no quenching. With increasing curcumin concentrations, an apparent combined effect of VC:VK3 and curcumin occurred in LNCaP cells, but not PC-3 cells. Quercetin alone was cytotoxic on both cell lines, but demonstrated an additional 50-percent cytotoxicity on PC-3 cells when combined with VC:VK3. VD3 was effective against both cell lines, with more effect on PC-3.

This effect was negated on LNCaP cells with the addition of VC:VK3. In conclusion, a natural antioxidant can enhance or decrease the cytotoxicity of an oxidizing anticancer system invitro, but generalizations about antioxidants cannot be made.

H.R.T. from Longevity Plus

Linda’s comment:  I began taking the H.R.T. from www.longevityplus.com  and happy that I did.  This is an awesome product….This H.R.T. isan herbal remedy  from Thailand.  Please read about it at the above web site.
 
Dr. Gordon’s Comments: What you must know about HRT, both kinds, the dangerous pharmaceutical version and the documented safe alternative herbal form, PUERARIA MIRIFICA. You can have happy menopausal patients without doubling their breast cancer recurrence rate. Just read this carefully and, if interested, ask Longevity Plus customer support to email you a packet of scientific information.

Anyone realizing that hormone therapy doubles recurrence of breast cancer should take the time to learn about the alternative to standard HRT that is Longevity Plus’s H.R.T. (Herbal Remedy from Thailand). Here we have epidemiological evidence that those consuming Pueraria Mirifica in their diet regularly have the lowest incidence of Breast Cancer according to the World Health Organization statistics.

Now your patients can have the improved quality of life that the ESTRIOL-like MIROESTROL component to H.R.T. provides without the increased risk of breast cancer associated with the pharmacological based HRT (Hormone Replacement Therapy) so widely used today in the US in spite of its known risks of heart disease and cancer.

Try H.R.T. on your next patient who has memory loss, insomnia, hot flashes, vaginal dryness and the other constellation of symptoms associated with menopause and see for yourself. Remember, the added ingredients in H.R.T. include the VITAL METHYLATION FACTORS like all 3 forms of Folic Acid and Methylcobalamin.  The published data about the more natural form of folic acid  5’MTHF shows it helps depression, even when antidepressants have not helped, and helps peripheral neuropathy, and improves memory, and helps to deal with endothelial vascular dysfunction ( vascular disease).

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

 
 
Excerpt: 
 HRT Doubles Recurrence Risk in Breast Cancer Survivors
LONDON, March 25 — Breast cancer survivors treated with hormone replacement therapy had a more than two-fold increased risk of recurrence or a contralateral malignancy, according to long-term follow-up data from a randomized clinical trial.

•Note that this is one of the few randomized, controlled studies that have examined the risk of breast cancer recurrence associated with HRT.
Those randomized to HRT had five-year breast cancer rates of 22.2% compared with 8% in women who received best patient care for menopausal symptoms without hormone therapy, Lars Holmberg, M.D., Ph.D., of King’s College London, and colleagues, reported in the April 2 issue of the Journal of the National Cancer Institute.

“The results of the HABITS [Hormonal Replacement after Breast Cancer -- Is It Safe?] trial indicate a substantial risk a new breast cancer event among breast cancer survivors using hormone therapy,” the authors concluded.

“Our results further suggest that hormone therapy not only induces and promotes breast cancer but may also stimulate the growth of tumor microdeposits in breast cancer survivors,” they added.

Despite the statistically significant impact of hormone therapy on breast cancer risk, the authors said more data from randomized studies are needed to define the risk and to clear up inconsistencies in prior studies.

However, Kathleen Pritchard, M.D., a breast cancer specialist at Sunnybrook Odette Cancer Center in Toronto, said in an accompanying editorial that the study “suggests quite definitively that there is a statistically significantly increased risk of recurrence in women given HRT following diagnosis of breast cancer.”

Persistent questions about the potential risks and benefits of HRT in breast cancer survivors provided impetus for several observational studies and analyses of case series. More recently, data from the Women’s Health Initiative and the Million Women Study provided additional compelling evidence of an increased risk of breast cancer among HRT users, the King’s College authors said.

 

 

 
 

Cancer Decisions – A Tipping Point For Homeopathy

Full article: http://www.cancerdecisions.com/content/view/414/2/lang,english/

Excerpt:

A landmark paper on homeopathy and cancer has appeared in the February 2010 issue of the International Journal of Oncology. Scientists at the University of Texas M.D. Anderson Cancer Center (MDA), led by Moshe Frenkel, MD, have confirmed the ability of four homeopathic remedies to induce apoptosis (programmed cell death) in breast cancer cell lines in the laboratory. The scientists in question were from the Integrative Medicine Program, the Department of Molecular Pathology, and the Department of Melanoma Medical Oncology of MDA. Their two Indian collaborators were from the Banerji Homeopathic Research Foundation, Kolkata, India, where these same remedies are employed clinically with apparent success. The four ultra-dilute remedies in question were Carcinosin, Phytolacca, Conium and Thuja.

Concern Over Canned Foods

Linda’s comment.  All the more reason why you don’t eat GMO and moving into the world of organics is the safest way to save your health.   We must begin to make the move to cook only FRESH foods.  Soups are best is home-made and we all know that.  As consumers, WE CAN control the industry.  If consumers just STOP BUYING, then the industry will change.  It happened with baby bottles, so why can’t it happen with canned foods??  JUST SAY NO to canned foods. Continued

Association of Mycoplasmal Infections with Malignant Progression, Relapse and Stage in Breast Cancer

Association of Mycoplasmal Infections with Malignant Progression, Relapse and Stage in Breast Cancer Patients

Intracellular bacterial infections have historically been proposed as a cause of cancer [1,2].  Although bacterial involvement in malignant transformation and its reversal with antibiotic treatment have been demonstrated in animal models [3], there are few examples of direct involvement of bacteria in clinical transformation of malignant cells [4].  It seems more likely that the release of Reactive Oxygen Species (ROS) and other genotoxic molecules by intracellular bacteria play a role in progression to malignancy rather than the inception of cancer or transformation [5].  Reports in the literature indicate that over one-half of ovarian cancer patients have mycoplasmal infections in their tumors [6], and the incidence of infection in ovarian cancer was related to stage and survival [7].  Some results have been questioned on the basis of contamination in tissue culture [8], but most studies did not use culture procedures.  Therefore, we examined breast cancer patients to determine if there was a relationship between systemic mycoplasmal infections and progression of their breast cancers.  Examination of breast cancer patients showed mycoplasmal infections inside blood leukocytes (~50%+) not blood plasma or serum.  The most common species found were M. fermentans, M. pneumoniae and M. genitalium.  In contrast, in healthy adults the incidence of these species was low [9].  We found an association between stage, progression (measured by relapse after surgery) and presence of mycoplasmal infection(s) (P<0.001) in breast cancer.  The results suggest that intracellular mycoplasmal infections known to be associated with malignant progression are significantly related to progression and relapse due to metastasis of breast cancer.

Prof. Garth L. Nicolson

American Academy of Environmental Medicine 2005 Annual Meeting

The Institute for Molecular Medicine, Email: gnicolson@immed.org

 References
 1. Nuzum JW. Surg Gynecol Obstet 1925; 11:343-353.

2. Plata et al. J Infect Dis 1973; 128:588-598

3. Tsai et al. PNAS 1995; 92:10197-10201.

4. Feng et al. Mol Cell Biol 1999; 19:7995-8002.

5. Nicolson GL. JANA 2003; 6(3):22-28.

6. Chan et al. Gynecol Oncol. 1996; 63(2):258-260.

7. Camolai N. Can J Microbiol 2001; 47(8):691-697.

8. Quirk et al. Gynecol Oncol. 2001; 83(3):560-562.

9. Nicolson  et al.  J Chronic Fatigue Syndr 2000; 6(3):23-39.